Eagle Pharmaceuticals, Inc. (EGRX) Social Stream
EAGLE PHARMACEUTICALS INC (EGRX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EGRX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $52 | $46 | $49.666 | $15.21 | 226.54% |
| 2022-02-09 | 4 | $52 | $50 | $51 | $15.21 | 235.31% |
| 2022-03-31 | 4 | $52 | $49 | $50.333 | $15.21 | 230.92% |
| 2022-04-28 | 3 | $50 | $49 | $49.5 | $15.21 | 225.44% |
| 2022-06-06 | 3 | $50 | $47 | $48.5 | $15.21 | 218.87% |
| 2022-11-07 | 3 | $45 | $41 | $43 | $15.21 | 182.71% |
| 2022-11-08 | 2 | $41 | $37 | $39 | $15.21 | 156.41% |
| 2023-03-13 | 3 | $37 | $31 | $34 | $15.21 | 123.54% |
| 2023-03-14 | 3 | $33 | $31 | $32 | $15.21 | 110.39% |
| 2023-05-10 | 3 | $33 | $26 | $29.5 | $15.21 | 93.95% |
| 2023-07-25 | 2 | $26 | $26 | $26 | $15.21 | 70.94% |
| 2023-08-09 | 2 | $17 | $17 | $17 | $15.21 | 11.77% |
| NA | 1 | $NA | $NA | $NA | $15.21 | NA% |
Price Target Last Issued NA NA, NA
The Trend in the Analyst Price Target
EGRX's average price target has moved down $34.67 over the prior 39 months.
EGRX reports an average of 21.84% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-07 | 3 | 45 | 41 | 43.0 | 39.73 | 8.23% |
| 2023-03-13 | 3 | 37 | 31 | 34.0 | 25.51 | 33.28% |
| 2023-05-10 | 3 | 33 | 26 | 29.5 | 21.11 | 39.74% |
| 2023-05-10 | 2 | 26 | 26 | 26.0 | 21.11 | 23.16% |
| 2023-08-09 | 2 | 17 | 17 | 17.0 | 19.23 | -11.6% |
EGRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 1 | 0 | 0 | 1 | 1 | 2 |
The Trend in the Broker Recommendations
EGRX's average broker recommendation rating worsened by 0.75 over the prior 17 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, EAGLE PHARMACEUTICALS INC's number of analysts covering the stock is greater than 122.1% of them.
- In the context of all US stocks, EAGLE PHARMACEUTICALS INC's variance in analysts' estimates is lower than 4.64% of them.
- In terms of how EAGLE PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1137.54% of that group.
- EAGLE PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 795.65% of stocks in the small market cap category.
In the Pharmaceutical Products industry, ELDN, ARDX, and LRMR are the three stocks most similar to EAGLE PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for EGRX? Use POWR Ratings for clearer insight into price direction.